Skip to main content
Erschienen in: AIDS and Behavior 9/2022

23.02.2022 | Original Paper

HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020

verfasst von: Mehrdad Khezri, Mostafa Shokoohi, Ali Mirzazadeh, Fatemeh Tavakoli, Nima Ghalekhani, Ghazal Mousavian, Soheil Mehmandoost, Parvin Afsar Kazerooni, Ali Akbar Haghdoost, Mohammad Karamouzian, Hamid Sharifi

Erschienen in: AIDS and Behavior | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Injection drug use has been the leading route of HIV transmission in Iran. We assessed HIV prevalence, risk behaviors, and uptake of prevention services among people who inject drugs (PWID) in Iran between 2010 and 2020. We also examined the individual and environmental determinants of HIV among PWID. PWID were recruited in major cities across the country in three national bio-­behavioral surveillance surveys in 2010, 2014, and 2020. Participants were tested for HIV and interviewed using a behavioral questionnaire. Between 2010 and 2020, the prevalence of HIV (15.1% to 3.5%), receptive needle sharing (25.2% to 3.9%) and unprotected sex (79.4% to 65.2%) decreased. Moreover, uptake of free needle/syringe increased (57.4% to 87.9%), while uptake of free condoms remained relatively stable across the surveys (34.3% to 32.6%). Multivariable analysis for the 2020 survey showed that a history of homelessness, incarceration, and a longer injection career significantly increased the odds of HIV seropositivity. During the past decade, HIV prevalence and drug- and sexual-related risk behaviors decreased among Iranian PWID. However, individual and structural determinants continue to drive HIV among this population. HIV prevention, diagnosis, and treatment among marginalized PWID with a history of homelessness or incarceration and those who inject drugs for a longer period, should be further prioritized in HIV care planning and resource allocation in Iran.
Literatur
1.
Zurück zum Zitat Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed
2.
Zurück zum Zitat Meader N, Semaan S, Halton M, Bhatti H, Chan M, Llewellyn A, et al. An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. 2013;17(6):1963–78.PubMedCrossRef Meader N, Semaan S, Halton M, Bhatti H, Chan M, Llewellyn A, et al. An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. 2013;17(6):1963–78.PubMedCrossRef
3.
Zurück zum Zitat Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.PubMedPubMedCentralCrossRef Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84:102866.PubMedCrossRef Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84:102866.PubMedCrossRef
5.
Zurück zum Zitat Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014;11(6):e1001663.PubMedPubMedCentralCrossRef Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014;11(6):e1001663.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Mumtaz GR, Awad SF, Feizzadeh A, Weiss HA, Abu-Raddad LJ. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis. J Int AIDS Soc. 2018;21(3):e25102.PubMedPubMedCentralCrossRef Mumtaz GR, Awad SF, Feizzadeh A, Weiss HA, Abu-Raddad LJ. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis. J Int AIDS Soc. 2018;21(3):e25102.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.PubMedCrossRef Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.PubMedCrossRef
8.
Zurück zum Zitat Haghdoost A, Danesh A, Sharifi H, Shokoohi M, Khajehkazemi R, Mirzazadeh A. HIV Bio-Behavioral Surveillance Survey (BBSS) among people who inject drugs, IR Iran in 2014: project report. Tehran: HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIv Surveillance, Kerman University of Medical Sciences, Kerman, Iran. 2014. Haghdoost A, Danesh A, Sharifi H, Shokoohi M, Khajehkazemi R, Mirzazadeh A. HIV Bio-Behavioral Surveillance Survey (BBSS) among people who inject drugs, IR Iran in 2014: project report. Tehran: HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIv Surveillance, Kerman University of Medical Sciences, Kerman, Iran. 2014.
9.
Zurück zum Zitat Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Trans Infect. 2013;89(Suppl 3):iii29–32.CrossRef Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Trans Infect. 2013;89(Suppl 3):iii29–32.CrossRef
10.
Zurück zum Zitat Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag. 2017;6(2):65.PubMedCrossRef Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag. 2017;6(2):65.PubMedCrossRef
11.
Zurück zum Zitat Ministry of Health and Medical Education. Islamic Republic of Iran, AIDS progress report on monitoring of the United Nations general assembly special session on HIV and AIDS. National AIDS Committee Secretariat. 2015. Ministry of Health and Medical Education. Islamic Republic of Iran, AIDS progress report on monitoring of the United Nations general assembly special session on HIV and AIDS. National AIDS Committee Secretariat. 2015.
12.
Zurück zum Zitat Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci. 2012;12(2):81–7.PubMed Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci. 2012;12(2):81–7.PubMed
13.
Zurück zum Zitat Rahimi J, Gholami J, Amin-Esmaeili M, Fotouhi A, Rafiemanesh H, Shadloo B, et al. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis. Addiction. 2020;115(4):605–22.PubMedCrossRef Rahimi J, Gholami J, Amin-Esmaeili M, Fotouhi A, Rafiemanesh H, Shadloo B, et al. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis. Addiction. 2020;115(4):605–22.PubMedCrossRef
14.
Zurück zum Zitat Khajehkazemi R, Haghdoost A, Navadeh S, Setayesh H, Sajadi L, Osooli M, et al. Risk and vulnerability of key populations to HIV infection in Iran; knowledge, attitude and practises of female sex workers, prison inmates and people who inject drugs. Sex Health. 2014;11(6):568–74.PubMedCrossRef Khajehkazemi R, Haghdoost A, Navadeh S, Setayesh H, Sajadi L, Osooli M, et al. Risk and vulnerability of key populations to HIV infection in Iran; knowledge, attitude and practises of female sex workers, prison inmates and people who inject drugs. Sex Health. 2014;11(6):568–74.PubMedCrossRef
15.
Zurück zum Zitat Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/AIDS: trends in the Middle East and North Africa region. Int J Infect Dis. 2016;44:66–73.PubMedCrossRef Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/AIDS: trends in the Middle East and North Africa region. Int J Infect Dis. 2016;44:66–73.PubMedCrossRef
16.
Zurück zum Zitat Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:78–83.PubMedCrossRef Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:78–83.PubMedCrossRef
17.
Zurück zum Zitat Ekhtiari H, Noroozi A, Farhoudian A, Radfar SR, Hajebi A, Sefatian S, et al. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? Addiction. 2020;115(7):1395–403.PubMedCrossRef Ekhtiari H, Noroozi A, Farhoudian A, Radfar SR, Hajebi A, Sefatian S, et al. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? Addiction. 2020;115(7):1395–403.PubMedCrossRef
18.
Zurück zum Zitat Shokoohi M, Karamouzian M, Osooli M, Sharifi H, Fahimfar N, Haghdoost A, et al. Low HIV testing rate and its correlates among men who inject drugs in Iran. Int J Drug Policy. 2016;32:64–9.PubMedCrossRef Shokoohi M, Karamouzian M, Osooli M, Sharifi H, Fahimfar N, Haghdoost A, et al. Low HIV testing rate and its correlates among men who inject drugs in Iran. Int J Drug Policy. 2016;32:64–9.PubMedCrossRef
19.
Zurück zum Zitat Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A, et al. Dual unsafe injection and sexual behaviors for HIV infection among people who inject drugs in Iran. AIDS Behav. 2019;23(6):1594–603.PubMedPubMedCentralCrossRef Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A, et al. Dual unsafe injection and sexual behaviors for HIV infection among people who inject drugs in Iran. AIDS Behav. 2019;23(6):1594–603.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Khezri M, Karamouzian M, Sharifi H, Ghalekhani N, Tavakoli F, Mehmandoost S, et al. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey. Int J Drug Policy. 2021;97:103355.PubMedCrossRef Khezri M, Karamouzian M, Sharifi H, Ghalekhani N, Tavakoli F, Mehmandoost S, et al. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey. Int J Drug Policy. 2021;97:103355.PubMedCrossRef
21.
Zurück zum Zitat Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, et al. Respondent-driven sampling for identification of HIV-and HCV-infected people who inject drugs and men who have sex with men in India: a cross-sectional, community-based analysis. PLoS Med. 2017;14(11):e1002460.PubMedPubMedCentralCrossRef Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, et al. Respondent-driven sampling for identification of HIV-and HCV-infected people who inject drugs and men who have sex with men in India: a cross-sectional, community-based analysis. PLoS Med. 2017;14(11):e1002460.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Amsterdam: Elsevier; 2009. p. 193–201. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Amsterdam: Elsevier; 2009. p. 193–201.
23.
Zurück zum Zitat Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.PubMedPubMedCentralCrossRef Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat McAuley A, Palmateer NE, Goldberg DJ, Trayner KM, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315–24.PubMedCrossRef McAuley A, Palmateer NE, Goldberg DJ, Trayner KM, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315–24.PubMedCrossRef
25.
Zurück zum Zitat Avery L, Rotondi N, McKnight C, Firestone M, Smylie J, Rotondi M. Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study. BMC Med Res Methodol. 2019;19(1):1–13.CrossRef Avery L, Rotondi N, McKnight C, Firestone M, Smylie J, Rotondi M. Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study. BMC Med Res Methodol. 2019;19(1):1–13.CrossRef
26.
Zurück zum Zitat Saleem HT, Likindikoki S, Nonyane BA, Nkya IH, Zhang L, Mbwambo J, et al. Correlates of non-fatal, opioid overdose among women who use opioids in Dar es Salaam, Tanzania. Drug Alcohol Depend. 2021;218:108419.PubMedCrossRef Saleem HT, Likindikoki S, Nonyane BA, Nkya IH, Zhang L, Mbwambo J, et al. Correlates of non-fatal, opioid overdose among women who use opioids in Dar es Salaam, Tanzania. Drug Alcohol Depend. 2021;218:108419.PubMedCrossRef
27.
Zurück zum Zitat Friedman J, Syvertsen JL, Bourgois P, Bui A, Beletsky L, Pollini R. Intersectional structural vulnerability to abusive policing among people who inject drugs: a mixed methods assessment in California’s central Valley. Int J Drug Policy. 2021;87:102981.PubMedCrossRef Friedman J, Syvertsen JL, Bourgois P, Bui A, Beletsky L, Pollini R. Intersectional structural vulnerability to abusive policing among people who inject drugs: a mixed methods assessment in California’s central Valley. Int J Drug Policy. 2021;87:102981.PubMedCrossRef
28.
Zurück zum Zitat Sharifi H, Mirzazadeh A, Shokoohi M, Karamouzian M, Khajehkazemi R, Navadeh S, et al. Estimation of HIV incidence and its trend in three key populations in Iran. PLoS ONE. 2018;13(11):e0207681.PubMedPubMedCentralCrossRef Sharifi H, Mirzazadeh A, Shokoohi M, Karamouzian M, Khajehkazemi R, Navadeh S, et al. Estimation of HIV incidence and its trend in three key populations in Iran. PLoS ONE. 2018;13(11):e0207681.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Akbari M, Fararouei M, Haghdoost AA, Gouya MM, Kazerooni PA. Survival and associated factors among people living with HIV/AIDS: a 30-year national survey in Iran. J Res Med Sci. 2019;24:5.PubMedPubMedCentralCrossRef Akbari M, Fararouei M, Haghdoost AA, Gouya MM, Kazerooni PA. Survival and associated factors among people living with HIV/AIDS: a 30-year national survey in Iran. J Res Med Sci. 2019;24:5.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Farhoudi B, Ghalekhani N, Afsar Kazerooni P, Namdari Tabar H, Tayeri K, Gouya MM, et al. Cascade of care in people living with HIV in Iran in 2019; how far to reach UNAIDS/WHO targets. AIDS Care. 2021;28:1–7. Farhoudi B, Ghalekhani N, Afsar Kazerooni P, Namdari Tabar H, Tayeri K, Gouya MM, et al. Cascade of care in people living with HIV in Iran in 2019; how far to reach UNAIDS/WHO targets. AIDS Care. 2021;28:1–7.
31.
Zurück zum Zitat Nakhaeizadeh M, Abdolahinia Z, Sharifi H, Mirzazadeh A, Haghdoost AA, Shokoohi M, et al. Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran. Harm Reduct J. 2020;17(1):1–8.CrossRef Nakhaeizadeh M, Abdolahinia Z, Sharifi H, Mirzazadeh A, Haghdoost AA, Shokoohi M, et al. Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran. Harm Reduct J. 2020;17(1):1–8.CrossRef
32.
Zurück zum Zitat Makarenko I, Ompad D, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L. Trends in injection risk behaviors among people who inject drugs and the impact of harm reduction programs in Ukraine, 2007–2013. J Urban Health. 2017;94(1):104–14.PubMedPubMedCentralCrossRef Makarenko I, Ompad D, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L. Trends in injection risk behaviors among people who inject drugs and the impact of harm reduction programs in Ukraine, 2007–2013. J Urban Health. 2017;94(1):104–14.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Mitsch AJ, Hall HI, Babu AS. Trends in HIV infection among persons who inject drugs: United States and Puerto Rico, 2008–2013. Am J Public Health. 2016;106(12):2194–201.PubMedPubMedCentralCrossRef Mitsch AJ, Hall HI, Babu AS. Trends in HIV infection among persons who inject drugs: United States and Puerto Rico, 2008–2013. Am J Public Health. 2016;106(12):2194–201.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Iran Drug Control Headquarters. Iran Drug Control Headquarter Year Book of 1394: Tehran: Drug Control Headquarter Publications; 2015. Iran Drug Control Headquarters. Iran Drug Control Headquarter Year Book of 1394: Tehran: Drug Control Headquarter Publications; 2015.
35.
Zurück zum Zitat Rahimi Movaghar A, Malayerikhah Langroodi Z, Delbarpour Ahmadi S, Amin EM. A qualitative study of specific needs of women for treatment of addiction. Iran J Psychiatry Clin Psychol. 2011;17(2):116–25. Rahimi Movaghar A, Malayerikhah Langroodi Z, Delbarpour Ahmadi S, Amin EM. A qualitative study of specific needs of women for treatment of addiction. Iran J Psychiatry Clin Psychol. 2011;17(2):116–25.
36.
Zurück zum Zitat Karamouzian M, Mirzazadeh A, Rawat A, Shokoohi M, Haghdoost AA, Sedaghat A, et al. Injection drug use among female sex workers in Iran: findings from a nationwide bio-behavioural survey. Int J Drug Policy. 2017;44:86–91.PubMedCrossRef Karamouzian M, Mirzazadeh A, Rawat A, Shokoohi M, Haghdoost AA, Sedaghat A, et al. Injection drug use among female sex workers in Iran: findings from a nationwide bio-behavioural survey. Int J Drug Policy. 2017;44:86–91.PubMedCrossRef
37.
Zurück zum Zitat Alam-Mehrjerdi Z, Daneshmand R, Samiei M, Samadi R, Abdollahi M, Dolan K. Women-only drug treatment services and needs in Iran: the first review of current literature. DARU J Pharm Sci. 2016;24(1):1–9. Alam-Mehrjerdi Z, Daneshmand R, Samiei M, Samadi R, Abdollahi M, Dolan K. Women-only drug treatment services and needs in Iran: the first review of current literature. DARU J Pharm Sci. 2016;24(1):1–9.
38.
Zurück zum Zitat Tavakoli F, Khezri M, Tam M, Bazrafshan A, Sharifi H, Shokoohi M. Injection and non-injection drug use among female sex workers in Iran: a systematic review and meta-analysis. Drug Alcohol Depend. 2021;221:108655.PubMedCrossRef Tavakoli F, Khezri M, Tam M, Bazrafshan A, Sharifi H, Shokoohi M. Injection and non-injection drug use among female sex workers in Iran: a systematic review and meta-analysis. Drug Alcohol Depend. 2021;221:108655.PubMedCrossRef
39.
Zurück zum Zitat Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–83.PubMedCrossRef Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–83.PubMedCrossRef
40.
Zurück zum Zitat Kakchapati S, Maharjan M, Rawal BB, Dixit SM. Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal. Arch Public Health. 2017;75(1):1–10.CrossRef Kakchapati S, Maharjan M, Rawal BB, Dixit SM. Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal. Arch Public Health. 2017;75(1):1–10.CrossRef
41.
Zurück zum Zitat Kermode M, Nuken A, Medhi GK, Akoijam BS, Sharma HU, Mahanta J. High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India. Indian J Med Res. 2016;143(3):348.PubMedPubMedCentralCrossRef Kermode M, Nuken A, Medhi GK, Akoijam BS, Sharma HU, Mahanta J. High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India. Indian J Med Res. 2016;143(3):348.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397–409.PubMedPubMedCentralCrossRef Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397–409.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021;6(5):e309–23.PubMedPubMedCentralCrossRef Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021;6(5):e309–23.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Topp L, Iversen J, Baldry E, Maher L. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013;90(4):699–716.PubMedCrossRef Topp L, Iversen J, Baldry E, Maher L. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013;90(4):699–716.PubMedCrossRef
45.
Zurück zum Zitat Linton SL, Celentano DD, Kirk GD, Mehta SH. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend. 2013;132(3):457–65.PubMedPubMedCentralCrossRef Linton SL, Celentano DD, Kirk GD, Mehta SH. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend. 2013;132(3):457–65.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Havens JR, Latkin CA, Pu M, Cornelius LJ, Bishai D, Huettner S, et al. Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. J Subst Abuse Treat. 2009;36(3):306–12.PubMedCrossRef Havens JR, Latkin CA, Pu M, Cornelius LJ, Bishai D, Huettner S, et al. Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. J Subst Abuse Treat. 2009;36(3):306–12.PubMedCrossRef
47.
Zurück zum Zitat Bretherton J, Pleace N. Housing first in England: an evaluation of nine services. 2015. Bretherton J, Pleace N. Housing first in England: an evaluation of nine services. 2015.
48.
Zurück zum Zitat Woodhall-Melnik JR, Dunn JR. A systematic review of outcomes associated with participation in Housing First programs. Hous Stud. 2016;31(3):287–304.CrossRef Woodhall-Melnik JR, Dunn JR. A systematic review of outcomes associated with participation in Housing First programs. Hous Stud. 2016;31(3):287–304.CrossRef
Metadaten
Titel
HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020
verfasst von
Mehrdad Khezri
Mostafa Shokoohi
Ali Mirzazadeh
Fatemeh Tavakoli
Nima Ghalekhani
Ghazal Mousavian
Soheil Mehmandoost
Parvin Afsar Kazerooni
Ali Akbar Haghdoost
Mohammad Karamouzian
Hamid Sharifi
Publikationsdatum
23.02.2022
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 9/2022
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-022-03627-3

Weitere Artikel der Ausgabe 9/2022

AIDS and Behavior 9/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.